PPARA rs1800206: What Your Genotype Means
The rs1800206 variant is a single nucleotide polymorphism located in the PPARA gene, which plays a central role in regulating lipid metabolism. Research suggests this variant may influence how an individual's body processes dietary fats and responds to exercise-induced changes in cholesterol levels.
What each genotype means
Typical lipid metabolism
This is the most common genotype for this variant, often referred to as the Leu162 allele. Research suggests individuals with this genotype generally maintain standard PPAR-alpha function, which is involved in regulating fatty acid metabolism and lipid clearance. Associations with lipid levels or dietary responses are less pronounced compared to those carrying the G allele.
This is the major genotype, carried by the vast majority of individuals across most global populations.
Altered lipid response
This genotype, which includes one copy of the Val162 variant, has been associated in some studies with differences in how the body processes dietary fats and responds to exercise. Some research indicates potential challenges in maintaining optimal HDL cholesterol levels or achieving ketosis, though findings are inconsistent across different studies. You should discuss your lipid profile and dietary goals with a healthcare provider or registered dietitian.
Carried by roughly 5-8% of people of European ancestry, with lower frequencies observed in East Asian populations.
Potential metabolic sensitivity
This genotype represents the homozygous Val162 variant, which may be associated with reduced PPAR-alpha activity in some research contexts. Some studies suggest this may influence triglyceride clearance and the body's ability to enter nutritional ketosis, though evidence remains limited and mixed. It is recommended to monitor your lipid markers and discuss any specific dietary or exercise interventions with a qualified clinician.
This is a rare genotype, occurring in less than 1% of most studied populations.
Understanding the rs1800206 Variant
The rs1800206 variant is a well-studied genetic change located within the PPARA gene on chromosome 22. In scientific literature, this specific change is often referred to as the Leu162Val polymorphism, indicating that it results in a substitution of the amino acid leucine for valine at position 162 of the PPAR-alpha protein. Because this change occurs in the coding region of the gene, it has the potential to alter the structure and function of the resulting protein. While once investigated for its potential link to specific lipid-related conditions, it is now widely classified in genomic databases as a common polymorphism rather than a direct cause of disease. It serves as a marker for researchers studying how subtle genetic differences contribute to the wide variation in metabolic health observed across different human populations.
The Role of the PPARA Gene
The PPARA gene provides instructions for making the peroxisome proliferator-activated receptor-alpha protein. This protein acts as a transcription factor, which is a type of protein that turns other genes on or off. PPAR-alpha is primarily active in tissues that require high amounts of energy, such as the liver, heart, and skeletal muscle. Its main job is to regulate the expression of genes involved in lipid metabolism, including the breakdown of fatty acids. By sensing the presence of dietary fats, PPAR-alpha helps the body maintain energy balance and manage cholesterol levels. Because of its central role in energy homeostasis, variations in the PPARA gene are frequently studied in the context of nutrigenomics—the field that explores how our genes interact with the nutrients we consume to influence overall health and metabolic outcomes.
Research Associations and Evidence Strength
Scientific research into rs1800206 has primarily focused on its association with plasma lipid concentrations and responses to dietary or exercise interventions. Some studies have observed that individuals carrying the G allele may experience different changes in high-density lipoprotein (HDL) or low-density lipoprotein (LDL) levels following specific dietary fat intake or aerobic training programs. However, the evidence supporting these associations is considered limited. Many studies have small sample sizes, and results can be inconsistent across different ethnic groups or study designs. Furthermore, the interaction between this variant and other genes, such as PPARG, complicates the picture, suggesting that the effect of rs1800206 is likely part of a complex, polygenic network rather than a standalone determinant of health. Consequently, these findings should be viewed as statistical observations in research settings rather than definitive predictors of an individual's health status.
Practical Considerations for Consumers
It is important to understand that genetic variants like rs1800206 do not function in isolation. While they provide interesting insights into biological variability, they are not diagnostic tools. If you have received information about your genotype for this variant, it is essential to recognize that lifestyle factors—such as overall diet quality, physical activity, and medical history—have a much more significant impact on your metabolic health than any single SNP. You cannot use this information to diagnose a condition or to make independent changes to your medical treatment. If you are concerned about your cholesterol levels, lipid profile, or how your diet affects your health, please discuss these topics with your primary care physician or a registered dietitian. They can provide personalized guidance based on your complete clinical picture, which is far more reliable than interpreting a single genetic marker in isolation.
How common is this variant?
The minor allele frequency for rs1800206 is approximately 0.05 to 0.08 in European populations, with lower frequencies observed in East Asian populations.
Frequently asked questions
Is rs1800206 a disease-causing mutation?
No, rs1800206 is classified as a polymorphism, which is a common genetic variation. It is not considered a direct cause of disease, though it may influence how your body responds to certain environmental factors.
Can I use this SNP to create a personalized diet?
While some research explores how this variant interacts with dietary fats, the evidence is not strong enough to support using it for personalized dietary prescriptions. Always consult a registered dietitian for evidence-based nutritional advice.
Does this variant affect my cholesterol levels?
Some studies suggest a statistical association between this variant and lipid levels, but these effects are often small and inconsistent. Your overall diet, exercise, and health history are much more important factors for your cholesterol.
Should I get tested for this variant?
There is no clinical recommendation to test for this variant. It is primarily used in research settings to understand the biological mechanisms of lipid metabolism rather than for routine clinical care.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800206?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PPARA
The PPARA Leu162Val missense substitution modulates fasting triglyceride levels and individual lipid responses to dietary polyunsaturated fatty acid (PUFA) intake.
Intron variant in PPARA associated with lipid substrate utilization and submaximal aerobic exercise capacity.
The PPARA Leu162Val polymorphism modulates fasting triglyceride and cholesterol responses to dietary polyunsaturated fatty acid (PUFA) intake.
Intronic regulatory polymorphism in PPARA associated with lipid metabolism and cardiovascular fitness profiles.
Influences PPARA expression and is associated with variations in cholesterol levels and response to dietary fat intake.
This SNP is associated with the capacity to improve VO2max in response to endurance training and metabolic efficiency.